Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

Contrast-enhanced Computed Tomography-Guided Percutaneous Cryoablation of Renal Cell Carcinoma in a Renal Allograft: First Case in Asia.

Tsuboi I, Araki M, Fujiwara H, Iguchi T, Hiraki T, Arichi N, Kawamura K, Maruyama Y, Mitsui Y, Sadahira T, Kubota R, Nishimura S, Sako T, Takamoto A, Wada K, Kobayashi Y, Watanabe T, Yanai H, Kitagawa M, Tanabe K, Sugiyama H, Wada J, Shiina H, Kanazawa S, Nasu Y.

Acta Med Okayama. 2019 Jun;73(3):269-272. doi: 10.18926/AMO/56871.

2.

T1a renal cell carcinoma on unenhanced CT: analysis of detectability and imaging features.

Gobara A, Yoshizako T, Yoshida R, Nakamura M, Shiina H, Kitagaki H.

Acta Radiol Open. 2019 May 13;8(5):2058460119849706. doi: 10.1177/2058460119849706. eCollection 2019 May.

3.

Xp11.2 translocation renal cell carcinoma with SFPQ/PSF-TFE3 fusion gene: A case report with unusual histopathologic findings.

Ishikawa N, Nagase M, Takami S, Nagano N, Araki A, Iwahashi T, Yamauchi N, Yamasaki T, Shiina H, Maruyama R.

Pathol Res Pract. 2019 May 26:152479. doi: 10.1016/j.prp.2019.152479. [Epub ahead of print]

PMID:
31153695
4.

Risk stratification by means of biological age-related factors better predicts cancer-specific survival than chronological age in patients with upper tract urothelial carcinoma: a multi-institutional database study.

Inamoto T, Matsuyama H, Ibuki N, Komura K, Fujimoto K, Shiina H, Sakano S, Nagao K, Miyake M, Yasumoto H, Azuma H; Nishinihon Uro-Oncology Collaborative Group.

Ther Adv Urol. 2018 Nov 11;10(12):403-410. doi: 10.1177/1756287218811050. eCollection 2018 Dec.

5.

Peritoneal dialysis-associated infection caused by Mycobacterium abscessus: a case report.

Yoshimura R, Kawanishi M, Fujii S, Yamauchi A, Takase K, Yoshikane K, Egawa M, Shiina H, Ito T.

BMC Nephrol. 2018 Nov 29;19(1):341. doi: 10.1186/s12882-018-1148-2.

6.

Appropriate radiation dose for symptomatic relief and local control in patients with adult T cell leukemia/lymphoma.

Maemoto H, Ariga T, Nakachi S, Toita T, Hashimoto S, Heianna J, Shiina H, Kusada T, Makino W, Kakinohana Y, Miyagi T, Yamamoto Y, Morishima S, Masuzaki H, Murayama S.

J Radiat Res. 2019 Jan 1;60(1):98-108. doi: 10.1093/jrr/rry068.

7.

Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study.

Nakajima K, Kaneko G, Takahashi S, Matsuyama H, Shiina H, Ichikawa T, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Mizokami A; PROSTAT-BSI Investigators.

Int J Urol. 2018 May;25(5):492-499. doi: 10.1111/iju.13556. Epub 2018 Apr 6.

8.

[8. How We Can Treat the Patients with Prostate Cancer-Surgical Option and Change over Time].

Shiina H, Sumura M, Kishi H, Yasumoto H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(2):208-218. doi: 10.6009/jjrt.2018_JSRT_74.2.208. Japanese. No abstract available.

9.

Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.

Miyake M, Tatsumi Y, Matsumoto H, Nagao K, Matsuyama H, Inamoto T, Azuma H, Yasumoto H, Shiina H, Fujimoto K; Nishinihon Uro-Oncology Collaborative Group.

BJU Int. 2018 May;121(5):764-773. doi: 10.1111/bju.14111. Epub 2018 Jan 21.

10.

Computed tomography-based image-guided brachytherapy for cervical cancer: correlations between dose-volume parameters and clinical outcomes.

Kusada T, Toita T, Ariga T, Maemoto H, Hashimoto S, Shiina H, Kakinohana Y, Heianna J, Nagai Y, Kudaka W, Aoki Y, Murayama S.

J Radiat Res. 2018 Jan 1;59(1):67-76. doi: 10.1093/jrr/rrx065.

11.

Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical Nephroureterectomy.

Inamoto T, Matsuyama H, Ibuki N, Komura K, Takahara K, Fujimoto K, Shiina H, Sakano S, Nagao K, Miyake M, Tatsumi Y, Yasumoto H, Azuma H; Nishinihon Uro-Oncology Collaborative Group.

J Urol. 2018 Apr;199(4):933-939. doi: 10.1016/j.juro.2017.10.019. Epub 2017 Oct 14.

PMID:
29037861
12.

Thermal Decomposition of Nitromethane and Reaction between CH3 and NO2.

Matsugi A, Shiina H.

J Phys Chem A. 2017 Jun 8;121(22):4218-4224. doi: 10.1021/acs.jpca.7b03715. Epub 2017 May 26.

PMID:
28521497
13.

[Laparoscopic Pyelolithotomy in a Horseshoe Kidney : A Case Report and Review of the Literature].

Yoshino T, Wake K, Sugitani T, Kodama K, Shiina H, Yasumoto H, Kadowaki A, Kawakami K.

Hinyokika Kiyo. 2017 Apr;63(4):157-161. doi: 10.14989/ActaUrolJap_63_4_157. Review. Japanese.

14.

1. Making a Diagnosis of Prostatic Disorders Based on the Recent Imaging Procedures.

Shiina H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2017;73(4):330-339. doi: 10.6009/jjrt.2017_JSRT_73.4.330. Japanese. No abstract available.

15.

Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma.

Mitsui Y, Shiina H, Kato T, Maekawa S, Hashimoto Y, Shiina M, Imai-Sumida M, Kulkarni P, Dasgupta P, Wong RK, Hiraki M, Arichi N, Fukuhara S, Yamamura S, Majid S, Saini S, Deng G, Dahiya R, Nakajima K, Tanaka Y.

Mol Cancer Res. 2017 Jul;15(7):884-895. doi: 10.1158/1541-7786.MCR-16-0444. Epub 2017 Feb 27.

16.

A Case Report of Bilateral Sarcomatoid Carcinoma of Adrenal Glands With Adrenal Insufficiency.

Ishikawa N, Nagase M, Takami S, Araki A, Ishikawa N, Koike C, Shiina H, Maruyama R.

Int J Surg Pathol. 2016 Dec;24(8):743-748. Epub 2016 Jun 27.

PMID:
27353077
17.

Changes in oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma treated in the last two decades: a retrospective analysis based on a multicenter collaborative study.

Miyake M, Tatsumi Y, Fujimoto K, Nagao K, Sakano S, Matsuyama H, Inamoto T, Azuma H, Yasumoto H, Shiina H; Nishinipon Uro-Oncology Collaborative Group.

Jpn J Clin Oncol. 2016 Dec;46(12):1148-1155. Epub 2016 Aug 30.

PMID:
27576438
18.

Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer.

Mitsui Y, Chang I, Kato T, Hashimoto Y, Yamamura S, Fukuhara S, Wong DK, Shiina M, Imai-Sumida M, Majid S, Saini S, Shiina H, Nakajima K, Deng G, Dahiya R, Tanaka Y.

Oncotarget. 2016 Aug 2;7(31):49107-49121. doi: 10.18632/oncotarget.9470.

19.

Time-Resolved Broadband Cavity-Enhanced Absorption Spectroscopy behind Shock Waves.

Matsugi A, Shiina H, Oguchi T, Takahashi K.

J Phys Chem A. 2016 Apr 7;120(13):2070-7. doi: 10.1021/acs.jpca.6b01069. Epub 2016 Mar 28.

PMID:
26990289
20.

The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).

Inoue K, Matsuyama H, Fujimoto K, Hirao Y, Watanabe H, Ozono S, Oyama M, Ueno M, Sugimura Y, Shiina H, Mimata H, Azuma H, Nagase Y, Matsubara A, Ito YM, Shuin T.

Photodiagnosis Photodyn Ther. 2016 Mar;13:91-96. doi: 10.1016/j.pdpdt.2015.12.011. Epub 2016 Jan 2.

PMID:
26751700
21.

CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.

Mitsui Y, Chang I, Fukuhara S, Hiraki M, Arichi N, Yasumoto H, Hirata H, Yamamura S, Shahryari V, Deng G, Wong DK, Majid S, Shiina H, Dahiya R, Tanaka Y.

BMC Cancer. 2015 Dec 1;15:942. doi: 10.1186/s12885-015-1951-0.

22.

Tissue Chromogranin A Expression during Prostate Cancer Progression: Prediction of Chemosensitivity.

Mitsui Y, Arichi N, Hiraki M, Harada Y, Yasumoto H, Shiina H.

Urol J. 2015 Jul 1;12(3):2165-72.

23.

Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.

Fukuhara S, Chang I, Mitsui Y, Chiyomaru T, Yamamura S, Majid S, Saini S, Deng G, Gill A, Wong DK, Shiina H, Nonomura N, Lau YF, Dahiya R, Tanaka Y.

Oncotarget. 2015 Jun 30;6(18):16341-51.

24.

Versican is a potential therapeutic target in docetaxel-resistant prostate cancer.

Arichi N, Mitsui Y, Hiraki M, Nakamura S, Hiraoka T, Sumura M, Hirata H, Tanaka Y, Dahiya R, Yasumoto H, Shiina H.

Oncoscience. 2015 Mar 2;2(2):193-204. eCollection 2015.

25.

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.

Mitsui Y, Hirata H, Arichi N, Hiraki M, Yasumoto H, Chang I, Fukuhara S, Yamamura S, Shahryari V, Deng G, Saini S, Majid S, Dahiya R, Tanaka Y, Shiina H.

Oncotarget. 2015 Apr 20;6(11):9577-91.

26.

DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.

Fukuhara S, Chang I, Mitsui Y, Chiyomaru T, Yamamura S, Majid S, Saini S, Hirata H, Deng G, Gill A, Wong DK, Shiina H, Nonomura N, Dahiya R, Tanaka Y.

Oncotarget. 2014 Nov 30;5(22):11297-307.

27.

Thermal decomposition of 1,1,1-trifluoroethane revisited.

Matsugi A, Yasunaga K, Shiina H.

J Phys Chem A. 2014 Dec 18;118(50):11688-95. doi: 10.1021/jp510227k. Epub 2014 Dec 5.

PMID:
25478995
28.

The relation between apparent diffusion coefficient and clinical stage of clear-cell renal cell carcinoma.

Nakamura T, Yoshizako T, Araki H, Maruyama M, Uchida K, Tamaki Y, Ishikawa N, Shiina H, Kitagaki H.

Clin Imaging. 2015 Jan-Feb;39(1):72-5. doi: 10.1016/j.clinimag.2014.09.006. Epub 2014 Oct 16.

PMID:
25457531
29.

Choroidal and cutaneous metastasis from urothelial carcinoma of the bladder after radical cystectomy: a case report and literature review.

Mitsui Y, Arichi N, Inoue K, Hiraki M, Nakamura S, Hiraoka T, Ishikawa N, Maruyama R, Yasumoto H, Shiina H.

Case Rep Urol. 2014;2014:491541. doi: 10.1155/2014/491541. Epub 2014 Nov 6.

30.

Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition.

Tamaki H, Harashima N, Hiraki M, Arichi N, Nishimura N, Shiina H, Naora K, Harada M.

Oncotarget. 2014 Nov 30;5(22):11399-412.

31.

Central vagal afferent endings mediate reduction of food intake by melanocortin-3/4 receptor agonist.

Campos CA, Shiina H, Ritter RC.

J Neurosci. 2014 Sep 17;34(38):12636-45. doi: 10.1523/JNEUROSCI.1121-14.2014.

32.

Shock tube study on the thermal decomposition of fluoroethane using infrared laser absorption detection of hydrogen fluoride.

Matsugi A, Shiina H.

J Phys Chem A. 2014 Aug 28;118(34):6832-7. doi: 10.1021/jp5066709. Epub 2014 Aug 11.

PMID:
25090102
33.

Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

Chang I, Fukuhara S, Wong DK, Gill A, Mitsui Y, Majid S, Saini S, Yamamura S, Chiyomaru T, Hirata H, Ueno K, Arora S, Shahryari V, Deng G, Tabatabai ZL, Greene KL, Shin DM, Enokida H, Shiina H, Nonomura N, Dahiya R, Tanaka Y.

Tumour Biol. 2014 Oct;35(10):10223-30. doi: 10.1007/s13277-014-2292-3. Epub 2014 Jul 17.

PMID:
25027399
34.

Case report of a ureteral obstruction by Candida albicans fungus balls detected by magnetic resonance imaging in kidney transplant recipient.

Arichi N, Yasumoto H, Ogawa K, Nagami T, Anjiki H, Nakamura S, Mitsui Y, Hiraoka T, Sumura M, Shiina H.

Exp Clin Transplant. 2014 Dec;12(6):559-61. doi: 10.6002/ect.2013.0235. Epub 2014 Jun 25.

35.

Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.

Mitsui Y, Yasumoto H, Nagami T, Hiraki M, Arichi N, Ishikawa N, Araki A, Maruyama R, Tanaka Y, Dahiya R, Shiina H.

Oncotarget. 2014 Apr 30;5(8):2198-207.

36.

Intraoperative fluorescence vascular imaging using indocyanine green for assessment of transplanted kidney perfusion.

Arichi N, Mitsui Y, Ogawa K, Nagami T, Nakamura S, Hiraoka T, Yasumoto H, Shiina H.

Transplant Proc. 2014;46(2):342-5. doi: 10.1016/j.transproceed.2013.11.129.

PMID:
24655959
37.

Excellent results of immunocomplex capture fluorescence analysis-I for cross-match test in renal transplantation.

Nishimura K, Hashimoto M, Kinoshita T, Shiraishi Y, Ueda N, Nakazawa S, Hirai T, Ishimura T, Kishikawa H, Nojima M, Yamamoto S, Fujisawa M, Shiina H, Ichikawa Y.

Transplant Proc. 2014;46(2):332-5. doi: 10.1016/j.transproceed.2013.11.148.

PMID:
24655956
38.

Coordination of bone morphogenetic protein 2 (BMP2) and aberrant canonical Wnt/β-catenin signaling for heterotopic bone formation in adrenal myelolipoma: A case report.

Mitsui Y, Yasumoto H, Hiraki M, Arichi N, Ishikawa N, Harada Y, Maruyama R, Shiina H.

Can Urol Assoc J. 2014 Jan-Feb;8(1-2):E104-7. doi: 10.5489/cuaj.1610.

39.

Comparison of utility of tumor size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma.

Maruyama M, Yoshizako T, Uchida K, Araki H, Tamaki Y, Ishikawa N, Shiina H, Kitagaki H.

Acta Radiol. 2015 Feb;56(2):250-6. doi: 10.1177/0284185114523268. Epub 2014 Feb 11.

PMID:
24518687
40.

Chain reaction mechanism in hydrogen/fluorine combustion.

Matsugi A, Shiina H, Tsuchiya K, Miyoshi A.

J Phys Chem A. 2013 Dec 27;117(51):14042-7. doi: 10.1021/jp410597n. Epub 2013 Dec 9.

PMID:
24289851
41.

Hybrid procedure using perineal and abdominal approaches for radical prostatocystectomy: initial experience with 16 select cases.

Mitsui Y, Yasumoto H, Anjiki H, Koike C, Arichi N, Hiraoka T, Sumura M, Honda S, Igawa M, Shiina H.

Springerplus. 2013 Jul 29;2:348. doi: 10.1186/2193-1801-2-348. eCollection 2013.

42.

Vagal afferent NMDA receptors modulate CCK-induced reduction of food intake through synapsin I phosphorylation in adult male rats.

Campos CA, Shiina H, Silvas M, Page S, Ritter RC.

Endocrinology. 2013 Aug;154(8):2613-25. doi: 10.1210/en.2013-1062. Epub 2013 May 28.

43.

Identification of lymphatic pathway involved in the spread of bladder cancer: Evidence obtained from fluorescence navigation with intraoperatively injected indocyanine green.

Inoue S, Shiina H, Mitsui Y, Yasumoto H, Matsubara A, Igawa M.

Can Urol Assoc J. 2013 May-Jun;7(5-6):E322-8. doi: 10.5489/cuaj.12096. Epub 2013 May 13.

44.

Simultaneous implantation of bilateral ureters into bladder acellular matrix graft after partial cystectomy in a porcine model.

Mitsui Y, Shiina H, Hiraoka T, Arichi N, Yasumoto H, Dahiya R, Tanagho EA, Igawa M.

BJU Int. 2012 Dec;110(11 Pt C):E1212-7. doi: 10.1111/j.1464-410X.2012.11553.x. Epub 2012 Oct 9.

45.

Editorial comment from Dr Shiina to Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: a meta-analysis.

Shiina H.

Int J Urol. 2012 Oct;19(10):921-2. doi: 10.1111/j.1442-2042.2012.03083.x. Epub 2012 Jul 17. No abstract available.

46.

Prediction of survival benefit using an automated bone scan index in patients with castration-resistant prostate cancer.

Mitsui Y, Shiina H, Yamamoto Y, Haramoto M, Arichi N, Yasumoto H, Kitagaki H, Igawa M.

BJU Int. 2012 Dec;110(11 Pt B):E628-34. doi: 10.1111/j.1464-410X.2012.11355.x. Epub 2012 Jul 12.

47.

Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.

Mitsui Y, Shiina H, Hiraki M, Arichi N, Hiraoka T, Sumura M, Honda S, Yasumoto H, Igawa M.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):487-96. doi: 10.1158/1055-9965.EPI-11-0970. Epub 2012 Jan 13.

48.

Indocyanine green (ICG)-based fluorescence navigation system for discrimination of kidney cancer from normal parenchyma: application during partial nephrectomy.

Mitsui Y, Shiina H, Arichi N, Hiraoka T, Inoue S, Sumura M, Honda S, Yasumoto H, Igawa M.

Int Urol Nephrol. 2012 Jun;44(3):753-9. doi: 10.1007/s11255-011-0120-x. Epub 2012 Jan 4.

PMID:
22215306
49.

[Essential effect of radical perineal prostatectomy on longitudinal alteration of QOL in patients with localized prostate cancer].

Shiina H, Yasumoto H, Igawa M, Inoue S.

Nihon Rinsho. 2011 Jun;69 Suppl 5:615-9. Japanese. No abstract available.

PMID:
22208054
50.

[Docetaxel-based combination chemotherapy for castration-resistant prostate cancer].

Urakami S, Shiina H, Igawa M.

Nihon Rinsho. 2011 Jun;69 Suppl 5:531-7. Japanese. No abstract available.

PMID:
22208039

Supplemental Content

Loading ...
Support Center